Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue.

@article{Ni2013AmyloidTD,
  title={Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue.},
  author={Ruiqing Ni and Per-G{\"o}ran Gillberg and Assar Bergfors and Amelia Marutle and A. Nordberg},
  journal={Brain : a journal of neurology},
  year={2013},
  volume={136 Pt 7},
  pages={2217-27}
}
Imaging fibrillar amyloid-β deposition in the human brain in vivo by positron emission tomography has improved our understanding of the time course of amyloid-β pathology in Alzheimer's disease. The most widely used amyloid-β imaging tracer so far is (11)C-Pittsburgh compound B, a thioflavin derivative but other (11)C- and (18)F-labelled amyloid-β tracers have been studied in patients with Alzheimer's disease and cognitively normal control subjects. However, it has not yet been established… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 43 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 85 references

Alzheimer’s disease

  • S Nyberg, ME Jonhagen, Z Cselenyi, C Halldin, P Julin, H Olsson
  • Eur J Nucl Med Mol Imaging
  • 2013

Comparison of the binding characteristics of [ 18 F ] THK523 and other amyloid imaging tracers to Alzheimerás disease pathology

  • R Harada, N Okamura, S Furumoto, T Tago, M Maruyama, M Higuchi
  • Eur J Nucl Med Mol Imaging
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…